These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35362006)
1. Cognitive impairment in multiple sclerosis: The role of the general practitioner in cognitive screening and care coordination. Longley WA; Honan C Aust J Gen Pract; 2022 Apr; 51(4):225-231. PubMed ID: 35362006 [TBL] [Abstract][Full Text] [Related]
2. Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective. Lechner-Scott J; Agland S; Allan M; Darby D; Diamond K; Merlo D; van der Walt A Mult Scler Relat Disord; 2023 Nov; 79():104952. PubMed ID: 37683558 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis. Miller E; Morel A; Redlicka J; Miller I; Saluk J Curr Neuropharmacol; 2018; 16(4):475-483. PubMed ID: 29119933 [TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research. Grzegorski T; Losy J Rev Neurosci; 2017 Nov; 28(8):845-860. PubMed ID: 28787275 [TBL] [Abstract][Full Text] [Related]
6. Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important? Oset M; Stasiolek M; Matysiak M Curr Neurol Neurosci Rep; 2020 May; 20(7):22. PubMed ID: 32444997 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169 [TBL] [Abstract][Full Text] [Related]
8. Timed instrumental activities of daily living in multiple sclerosis: The test of everyday cognitive ability (TECA). Charvet LE; Shaw MT; Sherman K; Haas S; Krupp LB Mult Scler Relat Disord; 2018 Jul; 23():69-73. PubMed ID: 29778936 [TBL] [Abstract][Full Text] [Related]
9. [Cognitive Impairment in Multiple Sclerosis]. Niino M; Miyazaki Y Brain Nerve; 2020 May; 72(5):509-515. PubMed ID: 32381748 [TBL] [Abstract][Full Text] [Related]
10. Early neuropsychological markers of cognitive involvement in multiple sclerosis. Eilam-Stock T; Shaw MT; Krupp LB; Charvet LE J Neurol Sci; 2021 Apr; 423():117349. PubMed ID: 33639421 [TBL] [Abstract][Full Text] [Related]
11. Detecting Subtle Cognitive Impairment in Multiple Sclerosis with the Montreal Cognitive Assessment. Charest K; Tremblay A; Langlois R; Roger É; Duquette P; Rouleau I Can J Neurol Sci; 2020 Sep; 47(5):620-626. PubMed ID: 32450922 [TBL] [Abstract][Full Text] [Related]
12. Exercise as a Countermeasure to Declining Central Nervous System Function in Multiple Sclerosis. Motl RW; Sandroff BM Clin Ther; 2018 Jan; 40(1):16-25. PubMed ID: 29287750 [TBL] [Abstract][Full Text] [Related]
13. Cognitive rehabilitation in multiple sclerosis. Longley WA Aust J Gen Pract; 2022 Apr; 51(4):233-237. PubMed ID: 35362007 [TBL] [Abstract][Full Text] [Related]
14. Identification of cognitive impairment, depression, and fatigue among multiple sclerosis patients in a large comprehensive care center: A mixed-methods, qualitative study. Tornatore C; Ahmad A; Pham T; Gupte-Singh K; Wahid N; Lynch J; Pratt KJ Mult Scler Relat Disord; 2022 Dec; 68():104117. PubMed ID: 36037754 [TBL] [Abstract][Full Text] [Related]
15. Cognitive assessment in multiple sclerosis clinical care: A qualitative evaluation of stakeholder perceptions and preferences. Elwick H; Smith L; Mhizha-Murira JR; Topcu G; Leighton P; Drummond A; Evangelou N; das Nair R Neuropsychol Rehabil; 2022 Aug; 32(7):1456-1474. PubMed ID: 33941045 [TBL] [Abstract][Full Text] [Related]